Lin Lin
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
- Surgery 29
- Helicobacter pylori-related gastroenterology studies 9
- Esophageal Cancer Research and Treatment 5
- Co-authors
- John L. Cameron (1 shared paper)He (5 shared papers)Shi Shi (4 shared papers)Yong (5 shared papers)Lisong Teng (1 shared paper)Liu - (5 shared papers)Wang (8 shared papers)Jin Jin (1 shared paper)
In The Last Decade
Lin Lin
192 papers receiving 7.3k citations
Lin Lin's Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 4.8k
- Cancer Research 1.9k
- Molecular Biology 2.7k
- Surgery 1.7k
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Lin Lin
This map shows the geographic impact of Lin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Lin more than expected).
Fields of papers citing papers by Lin Lin
This network shows the impact of papers produced by Lin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Lin. The network helps show where Lin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pancreatic Cancer Hit paper breakdown → | 2000 | 6314 |
| 2 | SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci | 2006 | 192 |
| 3 | The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma | 2006 | 41 |
| 4 | Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer | 2011 | 36 |
| 5 | Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China. | 2009 | 31 |
| 6 | Comprehensive profiling of EBV gene expression in nasopharyn- geal carcinoma through paired-end transcriptome sequencing | 2016 | 28 |
| 7 | Analysis of clinical manifestations of symptomatic acquired jejunoileal diverticular disease | 2005 | 27 |
| 8 | Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats | 2008 | 27 |
| 9 | 2013 | 24 | |
| 10 | Association of USP26 haplotypes in men in Taiwan, China with severe spermatogenic defect | 2008 | 23 |
| 11 | Study of liver cirrhosis over ten consecutive years in Southern China | 2014 | 22 |
| 12 | 2011 | 22 | |
| 13 | Histological Subtypes of Lung Cancer in Chinese Males from 2000 to 2012 | 2014 | 21 |
| 14 | Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C | 2012 | 20 |
| 15 | Biodegradation of malathion by Acinetobacterjohnsonii MA19 and optimization of cometabolism substrates | 2009 | 19 |
| 16 | Maximum standardized uptake value on PET/CT in preoperative assessment of lymph node metastasis from thoracic esophageal squamous cell carcinoma | 2014 | 16 |
| 17 | Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats | 2008 | 16 |
| 18 | Polymorphism on chromosome 9p21.3 contributes to early-onset and severity of coronary artery disease in non-diabetic and type 2 diabetic patients | 2011 | 16 |
| 19 | Nkx2-1： a novel tumor biomarker of lung cancer | 2012 | 15 |
| 20 | Comparative Pharmacokinetics of Florfenicol in Japanese Eels at Different Temperature | 2015 | 15 |
About Lin Lin
Lin Lin is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Epidemiology, having authored 208 papers that have together received 7.5k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (9 papers), Gastric Cancer Management and Outcomes (8 papers), Lung Cancer Treatments and Mutations (6 papers), Esophageal Cancer Research and Treatment (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers), Gastroesophageal reflux and treatments (5 papers) and Enzyme Production and Characterization (4 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (1.9k citations), Molecular Biology (2.7k citations), Surgery (1.7k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Lin Lin has collaborated with scholars based in China, Taiwan and Japan. Frequent co-authors include John L. Cameron, He, Shi Shi, Yong, Lisong Teng, Liu -, Wang, Jin Jin, Hồng and Luo. Their work appears in journals such as OncoTargets and Therapy, Rural and Remote Health, International Journal of Nanomedicine, British Journal of Urology and Journal of the Formosan Medical Association.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.